Found: 66
Select item for more details and to access through your institution.
Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case–control study.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 4, p. 475, doi. 10.1093/nop/npae029
- By:
- Publication type:
- Article
Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 2, p. 188, doi. 10.1093/nop/npad067
- By:
- Publication type:
- Article
The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort study.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 1, p. 75, doi. 10.1093/nop/npaa067
- By:
- Publication type:
- Article
International patterns of palliative care in neuro-oncology: a survey of physician members of the Asian Society for Neuro-Oncology, the European Association of Neuro-Oncology, and the Society for Neuro-Oncology.
- Published in:
- Neuro-Oncology Practice, 2015, v. 2, n. 2, p. 62, doi. 10.1093/nop/npu037
- By:
- Publication type:
- Article
Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience.
- Published in:
- European Journal of Breast Health, 2021, v. 17, n. 4, p. 371, doi. 10.4274/ejbh.galenos.2021.2021-4-10
- By:
- Publication type:
- Article
Brain metastases: Biology and the role of the brain microenvironment.
- Published in:
- Current Oncology Reports, 2001, v. 3, n. 6, p. 467, doi. 10.1007/s11912-001-0067-7
- By:
- Publication type:
- Article
Vaccine Therapies Against Gliomas: Prime Time Yet?
- Published in:
- Oncology (08909091), 2016, v. 30, n. 3, p. 222
- By:
- Publication type:
- Article
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1085, doi. 10.3390/cancers15041085
- By:
- Publication type:
- Article
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 174, doi. 10.3390/cancers11020174
- By:
- Publication type:
- Article
Micelle-templated, poly(lactic-co-glycolic acid) nanoparticles for hydrophobic drug delivery.
- Published in:
- International Journal of Nanomedicine, 2018, v. 13, p. 351, doi. 10.2147/IJN.S142079
- By:
- Publication type:
- Article
Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0244383
- By:
- Publication type:
- Article
Carpal tunnel syndrome associated with interleukin-2 therapy.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Role of Cysteine-rich 61 Protein (CCN1) in Macrophage-mediated Oncolytic Herpes Simplex Virus Clearance.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 9, p. 1678, doi. 10.1038/mt.2014.101
- By:
- Publication type:
- Article
Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.679702
- By:
- Publication type:
- Article
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1252, doi. 10.1093/neuonc/noab082
- By:
- Publication type:
- Article
Demystifying demethylator sensitivity in gliomas: role for TERT and DNMT1.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 7, doi. 10.1093/neuonc/noaa272
- By:
- Publication type:
- Article
Management of gliomas in patients with Lynch syndrome.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 1, p. 167, doi. 10.1093/neuonc/noaa227
- By:
- Publication type:
- Article
SNO 25th anniversary history series: Providing a global platform for communication and exchange in neuro-oncology.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1551, doi. 10.1093/neuonc/noaa219
- By:
- Publication type:
- Article
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 10, p. 1505, doi. 10.1093/neuonc/noaa062
- By:
- Publication type:
- Article
SNO 25th anniversary history series: Ancillary and satellite meetings of the Society for Neuro-Oncology.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 9, p. 1231, doi. 10.1093/neuonc/noaa211
- By:
- Publication type:
- Article
SNO 25<sup>th</sup> anniversary history series: The SNO Annual Meeting – A nexus for science, collaboration and community.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 8, p. 1053, doi. 10.1093/neuonc/noaa155
- By:
- Publication type:
- Article
SNO 25th anniversary history series: Investing in the membership of the Society for Neuro-Oncology.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 7, p. 897, doi. 10.1093/neuonc/noaa129
- By:
- Publication type:
- Article
Celebrating SNO's official journal, Neuro-Oncology.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 585, doi. 10.1093/neuonc/noaa070
- By:
- Publication type:
- Article
SNO 25<sup>th</sup> anniversary history series: Spotlight on Neuro-Oncology Practice and Neuro-Oncology Advances.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 6, p. 739, doi. 10.1093/neuonc/noaa108
- By:
- Publication type:
- Article
The Society for Neuro-Oncology: 20/20 vision for the future.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 435, doi. 10.1093/neuonc/noaa043
- By:
- Publication type:
- Article
CBMT-04. INDUCING MITOCHONDRIAL OXIDATIVE STRESS AND TARGETING CELLULAR STRESS RESPONSE BY INHIBITION OF NAMPT, THE RATE LIMITING ENZYME IN THE NAD+ SALVAGE PATHWAY IN GLIOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi33, doi. 10.1093/neuonc/noy148.123
- By:
- Publication type:
- Article
ACTR-30. PHASE 1B/2 STUDY TO ASSESS THE CLINICAL EFFECTS OF PAMIPARIB (BGB-290) IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY GLIOBLASTOMA (GBM).
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi17, doi. 10.1093/neuonc/noy148.063
- By:
- Publication type:
- Article
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1209, doi. 10.1093/neuonc/now051
- By:
- Publication type:
- Article
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 2, p. 266, doi. 10.1093/neuonc/nou155
- By:
- Publication type:
- Article
Implications of bevacizumab discontinuation in adults with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 6, p. 823, doi. 10.1093/neuonc/nou021
- By:
- Publication type:
- Article
Adult pilocytic astrocytomas: clinical features and molecular analysis.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 6, p. 841, doi. 10.1093/neuonc/not246
- By:
- Publication type:
- Article
Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 2, p. 303, doi. 10.1093/neuonc/not155
- By:
- Publication type:
- Article
Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 4, p. 406, doi. 10.1093/neuonc/nos309
- By:
- Publication type:
- Article
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 11, p. 1167, doi. 10.1093/neuonc/noq100
- By:
- Publication type:
- Article
Targeted Therapy for BRAF Mutant Brain Tumors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Brain metastasis from prostate carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 2, p. 363
- By:
- Publication type:
- Article
Quantitative validation of anti- PTBP1 antibody for diagnostic neuropathology use: Image analysis approach.
- Published in:
- International Journal for Numerical Methods in Biomedical Engineering, 2017, v. 33, n. 11, p. n/a, doi. 10.1002/cnm.2862
- By:
- Publication type:
- Article
Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Tumor microenvironment in glioblastoma: Current and emerging concepts.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad009
- By:
- Publication type:
- Article
Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac129
- By:
- Publication type:
- Article
miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.
- Published in:
- Genes, Chromosomes & Cancer, 2010, v. 49, n. 11, p. 981, doi. 10.1002/gcc.20808
- By:
- Publication type:
- Article
Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2747, doi. 10.1002/cncr.28031
- By:
- Publication type:
- Article
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 14, p. 3599, doi. 10.1002/cncr.26663
- By:
- Publication type:
- Article
Early imaging marker of progressing glioblastoma: a window of opportunity.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 629, doi. 10.1007/s11060-020-03565-x
- By:
- Publication type:
- Article
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 487, doi. 10.1007/s11060-016-2195-9
- By:
- Publication type:
- Article
Outcome of patients with malignant glioma and synchronous or metachronous non-central nervous system primary neoplasms.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 126, n. 3, p. 527, doi. 10.1007/s11060-015-1992-x
- By:
- Publication type:
- Article
Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 126, n. 2, p. 337, doi. 10.1007/s11060-015-1973-0
- By:
- Publication type:
- Article
A multi-resolution textural approach to diagnostic neuropathology reporting.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 124, n. 3, p. 393, doi. 10.1007/s11060-015-1872-4
- By:
- Publication type:
- Article